Title:
低用量酢酸シプロテロンを用いる、去勢された前立腺癌患者における血管運動症状の治療方法
Document Type and Number:
Japanese Patent JP2012505253
Kind Code:
A
Abstract:
The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
Inventors:
Ahmed Salah You.
Setia Sundeep
Leap catherine
Height Howard
Ben-Maimon Carroll S.
Setia Sundeep
Leap catherine
Height Howard
Ben-Maimon Carroll S.
Application Number:
JP2011531244A
Publication Date:
March 01, 2012
Filing Date:
October 12, 2009
Export Citation:
Assignee:
Teva Women's Health Incorporated
International Classes:
A61K31/57; A61K47/04; A61K47/20; A61K47/32; A61K47/36; A61P9/00; C07J53/00
Domestic Patent References:
| JPS5513261A | 1980-01-30 |
Foreign References:
| US6165504A | 2000-12-26 | |||
| US20040131553A1 | 2004-07-08 |
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto